Effect of Chemotherapy on Gonadal Function and Sexual Function of Male Cancer Survivors: A Review Article.
Urology journal./Urology jornal. · 27.11.2024 · 21 (6) · 361-368
DOI: 10.22037/uj.v21i.8030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Urology journal./Urology jornal., erschienen am 27.11.2024. Verfasst von Fatemeh Sodeifian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ftmhsodeifian@yahoo.com. Hauptthemen laut MEDLINE: Cancer Survivors, Sexual Dysfunction, Physiological, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: The advancement of anti-cancer treatment has increased survival rates among patients, yet putting them in an increased risk for developing side effects. In addition to early side effects, anti-cancer treatments, in particular chemotherapeutic medications can cause long-term side effects; fertility and sexual dysfunction included. The aim of this study was to review existing data on the effects of different chemotherapeutic agents on fertility and sexual function of male cancer survivors who received chemotherapy at different stages of life. METHODS: We searched PubMed/MEDLINE, Scopus, and Google Scholar to detect studies focused on the effect of chemotherapy on the gonadal/testicular function and sexual function of male cancer survivors. We restricted our search to English language publications and manuscript published before the year 2000 were excluded. RESULTS: It has been well understood that chemotherapy impairs gonadal function in a major number of cancer survivors and gonadal dysfunction is not protected if chemotherapeutic agents are administered before puberty in males. Moreover, the effect of chemotherapy on sexual function is controversial. CONCLUSION: While several articles reported the worst effect of chemotherapy on the sexual function of cancer survivors, some studies reported that chemotherapy does not impair sexual function. Higher levels of chemotherapy dose seem to be associated with more gonadal and sexual dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ftmhsodeifian@yahoo.com.
- Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ngh.kian78@yahoo.com.
- Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. hediyehbaghsheikhi@gmail.com.
- Clinical Research Development Unit of Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. farzadallame@gmail.com.
Zitieren
APA
Sodeifian, F., Kian, N., Baghsheikhi, H., & Allameh, F. (2024). Effect of Chemotherapy on Gonadal Function and Sexual Function of Male Cancer Survivors: A Review Article. Urology journal./Urology jornal., 21(6), 361-368. https://doi.org/10.22037/uj.v21i.8030
Vancouver
Sodeifian F, Kian N, Baghsheikhi H, Allameh F. Effect of Chemotherapy on Gonadal Function and Sexual Function of Male Cancer Survivors: A Review Article. Urology journal./Urology jornal.. 2024;21(6):361-368. doi:10.22037/uj.v21i.8030
BibTeX
@article{Sodeifian2024,
author = {Sodeifian, Fatemeh and Kian, Naghme and Baghsheikhi, Hediyeh and Allameh, Farzad},
title = {Effect of Chemotherapy on Gonadal Function and Sexual Function of Male Cancer Survivors: A Review Article},
journal = {Urology journal./Urology jornal.},
year = {2024},
volume = {21},
number = {6},
pages = {361--368},
doi = {10.22037/uj.v21i.8030}
}
EUVIMED